Owl Peak Labs
Private Company
Total funding raised: $3.2M
Overview
Owl Peak Labs is pioneering a novel diagnostic approach for early colorectal cancer detection using infrared thermal imaging. The company's SpectraGI platform captures subtle temperature and biochemical shifts in tissue, aiming to identify malignancies long before they are visible with traditional methods like colonoscopy. This technology has the potential to shift screening from reactive diagnosis to proactive prevention, significantly improving patient outcomes. As a private, pre-revenue diagnostics firm, Owl Peak is focused on developing and validating its platform for clinical use.
Technology Platform
Infrared spectral thermal imaging platform (SpectraGI) that detects metabolic heat patterns associated with cancerous and precancerous tissue in the gastrointestinal tract.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Competes in the enhanced endoscopy space against companies offering narrow-band imaging (Olympus), confocal laser endomicroscopy (Mauna Kea Technologies), and AI-based polyp detection software (Medtronic, Cosmo Pharmaceuticals). Must differentiate on the basis of unique metabolic data.